180 related articles for article (PubMed ID: 38878210)
1. Gasotransmitters and noble gases in cardioprotection: unraveling molecular pathways for future therapeutic strategies.
Pagliaro P; Weber NC; Femminò S; Alloatti G; Penna C
Basic Res Cardiol; 2024 Jun; ():. PubMed ID: 38878210
[TBL] [Abstract][Full Text] [Related]
2. The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
Andreadou I; Iliodromitis EK; Rassaf T; Schulz R; Papapetropoulos A; Ferdinandy P
Br J Pharmacol; 2015 Mar; 172(6):1587-606. PubMed ID: 24923364
[TBL] [Abstract][Full Text] [Related]
3. Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.
Penna C; Granata R; Tocchetti CG; Gallo MP; Alloatti G; Pagliaro P
Curr Drug Targets; 2015; 16(8):843-67. PubMed ID: 25751010
[TBL] [Abstract][Full Text] [Related]
4. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo.
Pagel PS; Krolikowski JG; Shim YH; Venkatapuram S; Kersten JR; Weihrauch D; Warltier DC; Pratt PF
Anesth Analg; 2007 Sep; 105(3):562-9. PubMed ID: 17717207
[TBL] [Abstract][Full Text] [Related]
5. Platelets and Cardioprotection: The Role of Nitric Oxide and Carbon Oxide.
Russo I; Barale C; Melchionda E; Penna C; Pagliaro P
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047079
[TBL] [Abstract][Full Text] [Related]
6. The Efficacy of Noble Gases in the Attenuation of Ischemia Reperfusion Injury: A Systematic Review and Meta-Analyses.
De Deken J; Rex S; Monbaliu D; Pirenne J; Jochmans I
Crit Care Med; 2016 Sep; 44(9):e886-96. PubMed ID: 27071065
[TBL] [Abstract][Full Text] [Related]
7. Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells.
Rizvi M; Jawad N; Li Y; Vizcaychipi MP; Maze M; Ma D
Exp Biol Med (Maywood); 2010 Jul; 235(7):886-91. PubMed ID: 20472713
[TBL] [Abstract][Full Text] [Related]
8. Argon Exposure Induces Postconditioning in Myocardial Ischemia-Reperfusion.
Lemoine S; Blanchart K; Souplis M; Lemaitre A; Legallois D; Coulbault L; Simard C; Allouche S; Abraini JH; Hanouz JL; Rouet R; Sallé L; Guinamard R; Manrique A
J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):564-573. PubMed ID: 28381122
[TBL] [Abstract][Full Text] [Related]
9. Involvement of glycogen synthase kinase-3β in liver ischemic conditioning induced cardioprotection against myocardial ischemia and reperfusion injury in rats.
Yang S; Abbott GW; Gao WD; Liu J; Luo C; Hu Z
J Appl Physiol (1985); 2017 May; 122(5):1095-1105. PubMed ID: 28153944
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial mechanisms by which gasotransmitters (H
Shemarova I; Nesterov V; Emelyanova L; Korotkov S
Front Biosci (Schol Ed); 2021 Dec; 13(2):105-130. PubMed ID: 34879465
[TBL] [Abstract][Full Text] [Related]
11. Noble Gases Therapy in Cardiocerebrovascular Diseases: The Novel Stars?
Zhang J; Liu W; Bi M; Xu J; Yang H; Zhang Y
Front Cardiovasc Med; 2022; 9():802783. PubMed ID: 35369316
[TBL] [Abstract][Full Text] [Related]
12. Strategies for gaseous neuromodulator release in chemical neuroscience: Experimental approaches and translational validation.
Ali R; Sen S; Hameed R; Nazir A; Verma S
J Control Release; 2024 Jan; 365():132-160. PubMed ID: 37972768
[TBL] [Abstract][Full Text] [Related]
13. Gasotransmitter Research Advances in Respiratory Diseases.
Jiang S; Chen H; Shen P; Zhou Y; Li Q; Zhang J; Chen Y
Antioxid Redox Signal; 2024 Jan; 40(1-3):168-185. PubMed ID: 37917094
[No Abstract] [Full Text] [Related]
14. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.
Ferdinandy P; Andreadou I; Baxter GF; Bøtker HE; Davidson SM; Dobrev D; Gersh BJ; Heusch G; Lecour S; Ruiz-Meana M; Zuurbier CJ; Hausenloy DJ; Schulz R
Pharmacol Rev; 2023 Jan; 75(1):159-216. PubMed ID: 36753049
[TBL] [Abstract][Full Text] [Related]
15. Noble gas and neuroprotection: From bench to bedside.
Yin H; Chen Z; Zhao H; Huang H; Liu W
Front Pharmacol; 2022; 13():1028688. PubMed ID: 36532733
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection Is in the Air-Inhaled Gases on Their Way to the Neurons.
Scheid S; Goebel U; Ulbrich F
Cells; 2023 Oct; 12(20):. PubMed ID: 37887324
[TBL] [Abstract][Full Text] [Related]
17. Noble gases as cardioprotectants - translatability and mechanism.
Smit KF; Weber NC; Hollmann MW; Preckel B
Br J Pharmacol; 2015 Apr; 172(8):2062-73. PubMed ID: 25363501
[TBL] [Abstract][Full Text] [Related]
18. Recent advances on endogenous gasotransmitters in inflammatory dermatological disorders.
Wang L; Xie X; Ke B; Huang W; Jiang X; He G
J Adv Res; 2022 May; 38():261-274. PubMed ID: 35572410
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
Heusch G
Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
[TBL] [Abstract][Full Text] [Related]
20. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
